Current stage-Stage I - Page 3 of 5 Posts on Medivizor
Navigation Menu

Current stage-Stage I Posts on Medivizor

Long-term effects of stereotactic ablative radiotherapy for patients with NSCLC

Posted by on May 2, 2017 in Lung cancer | 0 comments

In a nutshell The authors examined the long-term effects of stereotactic ablative radiotherapy (SABR) in treating patients with stage 1 non-small-cell lung cancer (NSCLC). They concluded that SABR is both safe and effective in the long-term. Some background SABR is a type of radiation used to treat inoperable early stage NSCLC. Studies have shown...

Read More

Surgery to treat stage 1 non-small cell lung cancer

Posted by on Apr 14, 2017 in Lung cancer | 0 comments

In a nutshell This trial examined different surgical techniques to treat early stage non-small-stage lung cancer. The authors concluded that there was no difference in effectiveness between three different surgical techniques for patients with early stage NSCLC.   Some background Early-stage non-small cell lung cancer (NSCLC) is commonly...

Read More

The beneficial effects of trastuzumab on locoregional control in HER2-positive breast cancer patients.

Posted by on Mar 27, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated the effects of trastuzumab (Herceptin) on the locoregional control (management in the area in which it arose) of patients with HER2-positive breast cancer (HER2+BC) following radiotherapy (RT). Trastuzumab administered alongside RT was found to be associated with a significantly reduced rate of locoregional...

Read More

Incidence of ovarian function recovery in women over 40 with chemotherapy induced amenorrhea

Posted by on Mar 13, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated ovarian function recovery (OFR) after chemotherapy-induced amenorrhea (absence of menstruation) in women aged 40-49 after 2 years of aromatase inhibitor (AI) therapy. The study concluded that a large number of women with chemotherapy-induced amenorrhea recover ovarian function during AI therapy.  Some...

Read More

Comparing axillary lymph node ultrasound and fine needle aspiration in breast cancer

Posted by on Mar 4, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether patients with a suspicious axillary lymph node (ALN) but negative fine-needle aspiration result (FNA) can be considered as having node-negative disease (AUN). The study concluded that patients with suspicious ALN on ultrasound but negative FNA results can be treated as having node-negative disease. Some...

Read More

Localized surgery outcomes in early rectal cancer

Posted by on Oct 29, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the outcomes of localized surgery following chemotherapy and radiation therapy (CRT) in rectal cancer. Researchers suggested that localized surgery should only be considered after a complete response to CRT.   Some background Radical surgery or total mesorectal excision (TME; bowel and lymph nodes around...

Read More

Searching for patients with stage 1 non-small cell lung cancer that cannot be surgically removed to undergo radiation therapy

Posted by on Apr 17, 2016 in Lung cancer | 0 comments

In a nutshell This phase 3 trial aims to compare the effectiveness of stereotactic body radiotherapy with conventional radiotherapy in patients with early stage non-small-cell lung cancer (NSCLC) that cannot undergo surgery for medical reasons. The main outcome of the trial will be absence of local recurrence (whether the cancer has come back at or...

Read More

LDH as an early predictor of cancer survival

Posted by on Feb 8, 2016 in Breast cancer | 14 comments

In a nutshell This study investigated the relationship between lactate dehydrogenase (LDH) levels and cancer-specific survival. Researchers concluded that LDH can be used as an early indicator of cancer outcomes. Some background Early cancer detection methods have significantly improved cancer survival rates. There is increasing evidence to...

Read More

LDH as an early predictor of cancer survival

Posted by on Feb 8, 2016 in Melanoma | 0 comments

In a nutshell This study investigated the relationship between lactate dehydrogenase (LDH) levels and cancer-specific survival. Researchers concluded that LDH can be used as an early indicator of cancer outcomes. Some background Early cancer detection methods have significantly improved cancer survival rates. There is increasing evidence to...

Read More